Ensuring Donated Drugs Get to Intended Patients
December 10, 2010
In an AEI Health Policy Outlook, Roger Bate, Legatum fellow in global prosperity, argues that "many [developing country] drug-distribution systems are plagued by waste, delay, and theft." As such, Bate writes that "[t]he U.S. government should conduct an independent review of practices at donor agencies such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) to ensure that drugs are used by those intended, rather than facilitating illegal parallel drug-distribution systems in recipient countries" (December 2010).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)